In two different transgenic mouse models of Alzheimer’s disease, APP/PS1 and 5xFAD, compound 79 significantly reduced both total Aβ and pyriform Aβ concentrations in the brain and restored cognitive function. Here, APP is linked to Alzheimer disease.